|SEQ_NO||1||Date of announcement||2021/07/12||Time of announcement||13:46:34|
|Subject||Announcement of TTY Biopharm's unaudited income information in June 2021|
|Date of events||2021/07/12||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2021/07/12
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $310,476 thousands (expressed in NT dollars; unaudited), a consolidated operating profit of $80,343 thousands, and a consolidated income before tax of $106,365 thousands in June 2021; net income attributed to stockholders of the parent company was $88,009 thousands; EPS is $0.35.
Year-to-date consolidated net sales was $2,007,025 thousands (in NT dollars; unaudited), a consolidated operating profit was $270,942 thousands and consolidated income before tax was $348,960 thousands until June 2021; year-to-date net income attributed to stockholders of the company was $238,587 thousands; EPS is $0.96.
7.Any other matters that need to be specified:
The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.